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Background: To determine the general appearance of normal axillary lymph nodes (LNs) in real-time tissue
sonoelastography and to explore the method0s potential value in the prediction of LN metastases.
Methods: Axillary LNs in healthy probands (n=165) and metastatic LNs in breast cancer patients (n=15) were
examined with palpation, B-mode ultrasound, Doppler and sonoelastography (assessment of the elasticity of the
cortex and the medulla). The elasticity distributions were compared and sensitivity (SE) and specificity (SP) were
calculated. In an exploratory analysis, positive and negative predictive values (PPV, NPV) were calculated based
upon the estimated prevalence of LN metastases in different risk groups.
Results: In the elastogram, the LN cortex was significantly harder than the medulla in both healthy (p=0.004) and
metastatic LNs (p=0.005). Comparing healthy and metastatic LNs, there was no difference in the elasticity
distribution of the medulla (p=0.281), but we found a significantly harder cortex in metastatic LNs (p=0.006). The SE
of clinical examination, B-mode ultrasound, Doppler ultrasound and sonoelastography was revealed to be 13.3%,
40.0%, 14.3% and 60.0%, respectively, and SP was 88.4%, 96.8%, 95.6% and 79.6%, respectively. The highest SE was
achieved by the disjunctive combination of B-mode and elastographic features (cortex >3mm in B-mode or blue
cortex in the elastogram, SE=73.3%). The highest SP was achieved by the conjunctive combination of B-mode
ultrasound and elastography (cortex >3mm in B-mode and blue cortex in the elastogram, SP=99.3%).
Conclusions: Sonoelastography is a feasible method to visualize the elasticity distribution of LNs. Moreover,
sonoelastography is capable of detecting elasticity differences between the cortex and medulla, and between
metastatic and healthy LNs. Therefore, sonoelastography yields additional information about axillary LN status and
can improve the PPV, although this method is still experimental.
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The prediction of axillary lymph node (LN) status
remains an important issue in the preoperative assess-
ment of breast cancer patients. Sentinel node biopsy
(SNB) is the standard option for women that are staged
with a negative nodal status [1-5]. Nevertheless, if axil-
lary metastases are suspected, the success of SNB may
be impaired. These patients should still receive axillary
LN dissection (ALND) [6,7]. The procedure of radical
ALND implies a significant increase in morbidity, such
as lymphedema or paresthesia of the arm [8]. Provided
that the preoperative assessment was correct, the preci-
sion of histological staging by SNB is very high and post-
operative morbidity is significantly minimized [9].
Recently, omission of radical ALND in certain cases of
positive sentinel nodes has been discussed [10,11].
However, the diagnostic precision of the preoperative
assessment of the axillary LN status is far from perfect.
Palpation of the axilla lacks sensitivity (SE) as only vast
metastases are clinically apparent. Mammography does
not fully cover the axillary region and the prediction of
the malignant or benign character of LNs is not possible.
On the other hand, B-mode ultrasound is known to be a
precise method for the examination of the axilla with a
SE of 45-73% and a specificity (SP) of 44-100%, depend-
ing on the distinct B-mode criteria that are investigated
[12,13]. Other imaging methods such as computer tom-
ography (CT), magnetic resonance imaging (MRI), scin-
timammography and positron emission tomography
(PET) have been investigated, but they have all demon-
strated no relevant clinical advantage in the evaluation
of the axilla. Additionally, they are overly expensive and
labor-intensive [14-19].
Therefore, ultrasound remains the most suitable im-
aging method to assess axillary LNs, although the diag-
nostic accuracy is still unsatisfactory [20]. Technical
advances like sonoelastography, tissue harmonic imaging
and increasing frequencies may allow a better differenti-
ation of benign and malignant masses [21-23]. Concern-
ing the evaluation of breast lesions, sonoelastography
has demonstrated an improved diagnostic performance
when combining this method with B-mode ultrasound
[22,24-26]. Sonoelastography has also been performed
on cervical [27-29], mediastinal [30,31], celiac or mesen-
teric [32,33] and inguinal [34] LNs.
However, to the best of our knowledge, no data con-
cerning sonoelastography of axillary LNs were published
prior to the studies of Choi et al. (n=64) and Taylor
et al. (n=50) in 2011 [35,36]. Therefore, our current
results from 165 healthy and 15 metastatic LNs may ex-
pand the knowledge in this field of research to a certain
degree.
Our primary study objective was to determine the typ-
ical color distributions of healthy LNs in the elastogram.The secondary study objective was an exploratory ana-
lysis of the method0s potential value in the prediction of
LN metastases when used as an adjunct to conventional
B-mode ultrasound.Materials and methods
Our study was carried out at the Breast Cancer Center
in the University Hospital of Saarland, Homburg/Saar,
Germany. The responsible ethics committee did not re-
quire additional approval for this non-interventional
study design. The study cohort (n=180 LNs) was
recruited from patients who attended the outpatient ser-
vice of our institution.
Healthy patients with no suspicious findings in the
breast examination were eligible for the control group
(group 1, n=165 LNs). In these patients, we performed
the experimental sonoelastography of a randomly chosen
axillary LN. Patients with a history of breast surgery
concerning a larger resection volume, inflammatory con-
ditions of the breast or systemic infections and skin dis-
orders were excluded.
Patients with histologically-proven breast cancer be-
fore treatment were potentially eligible for group 2. In
these patients, we performed experimental sonoelasto-
graphy of an ipsilateral axillary LN. These breast cancer
patients (n=33) were scheduled to undergo surgery of
the breast and the axilla. Concerning the previously
studied LN, we used a skin marker for identification and
correlated the pathological size with the ultrasono-
graphic size in order to ensure that this was a represen-
tative specimen. Eighteen patients had benign axillary
LNs on histological examination. These patients were
excluded from analysis. The remaining fifteen patients
showed metastases in the previously examined LN.
These patients were assigned to the metastatic group
(group 2, n=15 LNs).Ultrasound examinations and image analysis
The routine examinations were performed by the author
SW, a DEGUM (Deutsche Gesellschaft für Ultraschall in
der Medizin, German society for ultrasound in medi-
cine) level I certified senior physician in gynecology with
four years experience in breast ultrasound [37]. The
elastograms were obtained by the author JD, a doctoral
fellow at our institution. All examinations were per-
formed with the Hitachi EUB-8500 ultrasound system
(Hitachi Medical Systems GmbH, Wiesbaden, Germany)
using the Hitachi EUP-L54M probe (50 mm, 6–13
MHz) and the integrated elastography module [38].
First, each LN was measured in two planes (i.e. three
axes). Furthermore, we determined the dimension of the
cortex and the medulla and performed color Doppler
ultrasound. Pathological vascularization was defined as
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of the LN or an increased vascularization of the cortex.
Next, experimental sonoelastography was carried out.
The region of interest for the elastogram was chosen to
encompass a maximum of 30% LN tissue and a mini-
mum of 70% encircling tissue.
Image analysis was conducted by JD. As the analysis
was performed before surgery, JD had no information
about the final histological diagnosis in group 2. The
B-mode and Doppler images of each LN were described
by standard methods [39]. Concerning the elastogram,
the elasticity distribution of the cortex and medulla
were described as the predominant color of the par-
ticular anatomical region (red, yellow, green, turquoise
or blue).
Sonoelastography
Dynamic real-time examinations using ultrasound to
access the compressibility of breast lesions were intro-
duced in the 1980s [40]. Today, numerous ultrasound
manufacturers offer solutions that include elastography
modules in the various ultrasound platforms. The prin-
ciple of sonoelastography is that the tissue is subjected
to a stress (i.e. compression) and the resulting strain
(i.e. displacement) is assessed. Typically, the stress is
applied by compressing the tissue with the ultrasound
probe (freehand/handheld elastography). In addition, the
newly developed method of shear wave elastography is
under clinical evaluation [41]. This method utilizes an
acoustic push pulse (vertically directed) to induce an
elastic shear wave (horizontally directed) that propa-
gates through the tissue. The velocity of the shear
wave is measured by detection pulses and provides a
semi-quantitative measurement of tissue stiffness [42].
In our study, we applied handheld sonoelastographyFigure 1 Example for B-mode ultrasound and elastogram of a healthy
The predominant color of the medulla is green (with smaller areas of turqu
cortex, this case would be a false-positive.(Hitachi real-time tissue elastography, HI-RTE). This tech-
nology provides color elastograms, in which increasing
tissue hardness appears as red, green and blue in
ascending order on a continuous scale [Figures 1, 2, 3,
4, 5 and 6]. Therefore, the examiner receives informa-
tion about the mechanical properties of the tissue.Statistical analysis
MicrosoftW Office ExcelW 2007 (Microsoft Corporation)
was used for data collection. The analysis was performed
with MedCalcW 7.6 statistical software (MedCalc Software
bvba, Belgium). The Student's t-test was used for con-
tinuous data and comparison of means. Ultrasonographic
features of benign and malignant LNs were compared
using Fisher's exact test for univariate distributions. The
predominant colors in the elastograms were compared
using Yates' chi-square test for multivariate distributions
of categorical data. When Yates' chi-square test was
found to be significant, pairwise comparisons were per-
formed using Fisher's exact test. For the calculation of
95% confidence levels we used Newcombe intervals with
continuity correction [43]. Specimen histology was the
gold standard for the definition of metastatic LNs. Statis-
tical significance was assumed at p<0.05 for all tests.Results
We analyzed 165 healthy LNs (group 1) and 15 meta-
static LNs (group 2). The breast cancer patients (group
2) were significantly older (58.3 ± 7.4 versus 50.2 ± 12.9
years, p=0.017), and had a significantly higher body mass
index (28.0 ± 5.2 versus 24.8 ± 4.5 kg/m2, p=0.012) than
the healthy probands (group 1). There was no significant
difference between the groups regarding the clinical
presentation of the LNs (i.e. palpable mass 13.3% versusLN. In B-mode ultrasound the LN exhibits no criteria for malignancy.
oise) and the cortex is mainly blue. Applying the criterion of a blue
Figure 2 Example for B-mode ultrasound and elastogram of a healthy LN. In B-mode ultrasound the LN exhibits no criteria for malignancy.
The predominant color of the medulla is turquoise (with smaller areas of green) and the cortex is mainly green. Applying the criterion of a blue
cortex, this case would be a true-negative.
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p=1.000).
B-mode features and Doppler features of healthy and
metastatic lymph nodes
Regarding the horizontal size of the LNs and the diam-
eter of the medulla, there were no significant differences
between the groups. Nevertheless, the vertical dimension
of metastatic LNs was significantly higher (9.2mm versus
7.2mm, p=0.013). Focusing on the cortex, we found a
significantly broader cortex for the metastatic LNs
(4.2mm versus 1.4mm, p<0.001). Consequently, the cor-
tex-to-medulla-ratio as well as the vertical-to-horizontal-
size were significantly higher in the metastatic group
(p<0.001 and p=0.002, respectively). A cortex greater
than 3mm was found in only 3.1% of the healthy LNs,
compared to 40.0% of the metastatic LNs (p<0.001). The
results are shown in Table 1.Figure 3 Example for B-mode ultrasound and elastogram of a healthy
enlarge (maximum ~2.5mm). The predominant color of the medulla is gree
(with smaller areas of green). Applying the criterion of a blue cortex, this caElastograms of healthy and metastatic lymph nodes
Focusing on the group of healthy LNs (n=165), the
predominant color of the cortex was yellow in 1.2%,
green in 13.9%, turquoise in 64.2% and blue in 20.6%
of the cases respectively, and never red [Table 2]. The
medulla exhibited a similar distribution of the colors
(3.0%, 15.8%, 73.9% and 73.2%, respectively, never red)
[Table 3]. Nevertheless, the cortex and medulla color
distributions were significantly different in the multivariate
analysis (p=0.004), and the pairwise comparison revealed
that the cortex was significantly more often described as
blue (i.e. hard) than the medulla (p<0.001).
Focusing on the group of metastatic LNs (n=15), the
predominant color of the cortex was either turquoise
(40.0%) or blue (60.0%) but never yellow, green or red
[Table 2]. The medulla was yellow in 6.7%, green in
33.3%, turquoise in 53.3% and blue in 6.7% of cases, re-
spectively [Table 3]. Accordingly, the difference between, reactive LN. In B-mode ultrasound the cortex of the LN is slightly
n (with smaller areas in other shades) and the cortex is mainly blue
se would be a false-positive.
Figure 4 Example for B-mode ultrasound and elastogram of a healthy, reactive LN. In B-mode ultrasound, the cortex of the LN is slightly
enlarged (maximum ~3.5mm). The predominant color of the medulla is turquoise (to green) and the cortex is mainly green. Applying the
criterion of a blue cortex, this case would be a true-negative.
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the multivariate analysis (p=0.005).
Comparing the two groups, there was no difference
regarding the color distribution of the medulla [Table 3].
However, we found a significant difference regarding the
color distribution of the cortex (p=0.005). Compared to
healthy LNs, the cortex of metastatic LNs was signifi-
cantly more often blue (60.0% versus 20.6%, p=0.005)
[Table 2].
Sensitivity and specificity of B-mode ultrasound, Doppler
ultrasound, sonoelastography and clinical examination
Analyzing the performance of single criteria, a cortex
broader than 3mm in B-mode ultrasound yielded an ex-
cellent specificity (96.8%) and a low sensitivity (40.0%).
Concerning sonoelastography, we applied the criterion
of a blue cortex and achieved a well-balanced specificity
of 79.6% and a sensitivity of 60.0%.Figure 5 Example for B-mode ultrasound and elastogram of a metast
enlarged (maximum ~3.5mm). The predominant color of the medulla is tu
of a blue cortex, this case would be a true-positive.In order to explore the combinations of different ultra-
sound criteria, we combined the B-mode feature ″cortex
broader than 3mm″ and the elastographic feature ″blue
cortex″. In the disjunctive combination (LNs that fulfill
at least one criterion were regarded as positive), the spe-
cificity was 77.5% and the sensitivity was higher than
with any other criterion, namely 73.3%. In the conjunc-
tive combination (only LNs that fulfill both criteria were
regarded as positive), the specificity reached an excellent
level of 99.3% (higher than with any other criterion) and
the sensitivity was 26.7% [Table 4].
Model calculation concerning the diagnostic performance
of B-mode ultrasound and sonoelastography
Calculation of the negative and positive predictive values
(NPV, PPV) should be based on the particular preva-
lence in the observed collective. The prevalence of LN
metastases in individual subgroups is dependent on theatic LN. In B-mode ultrasound, the cortex of the LN is slightly
rquoise (to green) and the cortex is mainly blue. Applying the criterion
Figure 6 Example for B-mode ultrasound and elastogram of a metastatic LN. In B-mode ultrasound, the cortex of the LN is slightly
enlarged (maximum ~3.0mm). The predominant color of the medulla is turquoise and cortex is mainly blue. Applying the criterion of a blue
cortex, this case would be a true-positive.
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lectives, the prevalence of LN metastases is estimated to
be about 45% [47], which is concordant with our collect-
ive (45.5%). In particular, tumors categorized as T1 show
LN metastases in about 25.9% of cases, whereas in T2
tumors, LN metastases occur in about 48.2% [48]. Based
on the prevalence of LN involvement within these two
risk groups, the following predictive values result:
In T1 tumors (with an estimated prevalence of LN me-
tastases of 25.9%), the best B-mode criterion (cortex
>3mm) can be expected to yield a PPV of about 81%
and an NPV of ~82%. The conjunctive combination with
the best elastographic criterion (blue cortex) leads to an
improved PPV of ~93% with little effect on the NPV
(~79%).
In T2 tumors (with an estimated prevalence of LN
metastases of 48.2%), B-mode ultrasound can be expected
to have a PPV of ~92% and a NPV of ~63%. TheTable 1 B-mode features and Doppler sonography of healthy
n.s. = not significant, LN = lymph node)
LN characteristics Group 1 healthy LNs
n 165
Distance from the skin (mm) 13.5 ± 5.1
Horizontal size (mm) 15.8 ± 6.4
Vertical size (mm) 7.2 ± 3.0
Vertical-to-horizontal-size (ratio) 0.50 ± 0.24
Cortex (mm) 1.4 ± 0.7
Medulla (mm) 4.8 ± 2.4
Cortex-to-medulla (ratio) 0.39 ± 0.31
Cortex >3mm 3.1%
Architectural distortions 0.6%
Pathologic vascularization 4.4%conjunctive combination with sonoelastography improves
the PPV (~97%), but also impairs the NPV (~59%).Discussion
Sonoelastography only offers a relative measurement of
tissue stiffness and is dependent on the surrounding tis-
sue [49]. We propose a relatively simple criterion (i.e.
blue cortex) as the most suitable predictor of malignancy
in LNs. The fact that the cortex of metastatic LNs is sig-
nificantly harder than the cortex of healthy LNs is
reflected in the predominance of the colors blue and tur-
quoise in the elastograms. Applying this single criterion,
the examination with sonoelastography resulted in an SE
of 60.0% and an SP of 79.6%.
However, the combination of various criteria from sev-
eral imaging methods is known to improve the perform-
ance. This principle is also used in breast diagnostics,and metastatic LNs (mean ± standard deviation,
Group 2 metastatic LNs p
15
15.5 ± 3.0 n.s. (0.126)
14.4 ± 7.0 n.s. (0.406)
9.2 ± 3.5 0.013
0.70 ±0.26 0.002
4.2 ± 4.7 <0.001
4.1 ± 2.1 n.s. (0.299)




Table 2 Predominant color of the cortex in sonoelastography with respect to healthy and metastatic LNs
Cortex Group 1 healthy LNs n=165 Group 2 metastatic LNs n=15 p (pairwise comparison)
red (soft) 0% 0% n.a.
yellow 1.2% 0% n.s. (1.000)
green 13.9% 0% n.s. (0.223)
turquoise 64.2% 40.0% n.s. (0.093)
blue (hard) 20.6% 60.0% 0.001
p-value (multivariate analysis) 0.006
The cortex of metastatic LNs is significantly harder and therefore significantly more often described as blue than the cortex of healthy LNs. (n.s. = not significant,
n.a. = not applicable, LN = lymph node).
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bined, or mammography and MRI are added [50]. Con-
sequently, we combined our best B-mode criterion and
the most plausible elastographic criterion in order to in-
vestigate the effect on SE and SP. The conjunctive com-
bination of B-mode and sonoelastography resulted in an
improved performance. Due to the high specificity of the
method, the PPV increased, while the effect on the NPV
was only marginal and without clinical relevance.
However, a false negative preoperative evaluation usu-
ally results in the resection of a metastatic involved sen-
tinel node. This scenario implies no relevant risk to the
patient. On the other hand, a false positive evaluation of
axillary LN status may result in an unnecessary axillary
dissection instead of sentinel node biopsy with a poten-
tially increased morbidity. Therefore, a beneficial effect
of the complementary use of sonoelastography is very
likely. We propose that these aspects should be investi-
gated further.Literature overview
Concerning breast masses, a scoring system (the so-
called Tsukuba Elasticity Score, Itoh Score or Elasticity
Score) is commonly used, which refers to the distribu-
tion of different colors within a lesion [51]. Obviously,
this scoring system was developed for breast lesions and
is not applicable to LNs.
For the elastographic assessment of cervical LNs,
Lyshchik et al. determined an individual four-point rating
scale including the visibility, relative brightness, marginTable 3 Predominant color of the medulla in sonoelastograph






p-value (multivariate analysis) n.s.
There is no difference between the two groups. (n.s. = not significant, n.a. = not apregularity, and margin definition of the LNs in the elasto-
gram. In the evaluation of 141 patients, they described
an SP of 98%, an SE of 85% and an accuracy of
92% [27].
Saftiou et al. reported on cervical, mediastinal and ab-
dominal LNs examined with endoscopic ultrasound elas-
tography. The evaluation of the pictures was performed
using a pattern analysis with RGB channel histograms.
In their collective study of 42 LNs, they achieved an SP
of 94.4% and an SE of 91.7% [52].
Taylor et al. performed sonoelastography in 50 breast
cancer patients. They evaluated the LNs in the elasto-
gram with either an individual visual scoring system
or an individual strain scoring system. The authors
described an SE and SP of 76% and 78% for conventional
ultrasound, 90% and 86% for visual scoring, and 100%
and 48% for strain scoring, respectively [36].
Alam et al. published data on cervical LNs in 85
patients. The authors analyzed the distribution and per-
centage of the LN area with high elasticity (i.e. hard,
blue), with pattern 1 being an absent or very small hard
area and pattern 5 indicating a hard area occupying the
entire LN. The cutoff line for reactive versus metastatic
was set between patterns 2 and 3. The authors reported
an SE of 83% and an SP of 100% [28].
Choi et al. modified this system and classified 64 axil-
lary LNs using a 4-point color scale based on the per-
centage and distribution of the LN areas with high
elasticity (i.e. hard, blue). They achieved an SE of 80.7%
and an SP of 66.7% [35]. These results do not fully com-
ply with the previously described studies and our owny with respect to healthy and metastatic LNs







plicable as the multivariate analysis was negative, LN = lymph node).
Table 4 Sensitivity and specificity of conventional
ultrasound, Doppler and sonoelastography for the
assessment of axillary LNs including conjunctive and
disjunctive combinations (95% confidence intervals in
brackets)
Prediction of LN status Sensitivity Specificity
B-Mode-US: Cortex >3mm 40.0 96.8
(17.5-67.1) (92.5-98.8)
Doppler-US: Pathologic vessels 14.3 95.6
(2.5-43.9) (90.8-98.1)
Clinical examination: Palpable LNs 13.3 88.4
(2.3-41.6) (82.3-92.7)
Elastogram: Cortex ″blue″ 60.0 79.6
(32.9-82.5) (72.2-85.5)
Disjunctive combination:
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observed in elastography.
Generally, the performance of sonoelastography is
remarkably good in studies from the literature. Never-
theless, we have to consider that these data are from
dissimilar, small patient collectives, the LNs are exam-
ined in different regions of the body, and the methods
show relevant variations. Therefore, more advanced com-
parisons of the data are not possible.
Despite these reports, we have chosen a different
approach for the evaluation of the elastograms, as we
propagate the idea that the cortex and the medulla of an
LN should be evaluated separately. Furthermore, we tried
to avoid cumbersome scoring systems. For the evaluation
of the elastograms we used a simple 5-point color scale
describing the predominant color of the distinct struc-
ture (red, yellow, green, turquoise, or blue) as it appears
in the elastogram.
Our approach is concordant with the preliminary
results of Giovannini et al., who investigated LNs with
endoscopic sonoelastography in 49 patients. The authors
described a high SE (100%) and a moderate SP (50%) for
sonoelastography using the criterion of a homogeneously
blue cortex [33].
Metastases develop preferentially in the LN cortex and
cause tissue alterations. As demonstrated by our results,
sonoelastography seems to be capable of detecting these
minute changes in elasticity distribution, although the
LN cortex only constitutes a tissue structure of a few
millimeters in size.
Another option for the interpretation of elastograms is
the calculation of the strain-ratio [24,25]. This mode hasnot been systematically analyzed in LNs and could be a
matter for future research.
Limitations of our study
The main limitation of our study is that we have no vali-
dated criteria for the description of LNs in the elasto-
gram. Accordingly, the analysis of the predominant color
is, to a certain degree, observer-dependent, as it is based
on image interpretation. Nevertheless, the evaluation of
B-mode images is also observer-dependent and a matter
of subjective interpretation. To minimize this limitation,
we chose a simplified evaluation algorithm based on five
categories (predominant color described as red, yellow,
green, turquoise, or blue). The analysis of inter-observer
concordance could be a matter for future research.
Furthermore, the still image of the elastogram is ran-
domly depicted by the examiner during the real-time
examination. This implies the risk of an observation
bias. Nevertheless, this is unavoidable and has proven
stable results in previous elastographic studies of
LNs [52].
Finally, the analysis of SP, PPV and NPV is limited by
the fact, that a group of healthy women is probably not
the optimal choice for the control group, as lymph node
morphology may differ even between healthy women
and node negative breast cancer patients. Furthermore,
there are vast confidence intervals around parameter
estimated due to the small sample size. Further studies
with larger collectives consisting exclusively of breast
cancer patients may yield more accurate results.
Conclusion
– The cortex of healthy LNs is typically harder (i.e.
has a higher elasticity) than the medulla.
– The cortex of malignant LNs is typically harder (i.e.
has a higher elasticity) than the medulla.
– Comparing healthy LNs and metastatic LNs, the
cortex of metastatic LNs is significantly harder (i.e.
has a higher elasticity) than the cortex of healthy
LNs.
– The definition of a blue cortex in the elastogram as
a criterion for malignancy is feasible.
– Concerning the prediction of LN status, the
combination of B-mode ultrasound with
sonoelastography may be superior to B-mode
ultrasound alone.
– The best specificity (99.3%) may be achieved by
conjunctively combining B-mode ultrasound with
the elastogram (cortex >3mm and cortex blue),
although the sensitivity is low in this setting (26.7%).
– The conjunctive combinations of B-mode
ultrasound and sonoelastography may improve the
PPV (i.e. reduced false positive rate), but there may
Wojcinski et al. BMC Medical Imaging 2012, 12:35 Page 9 of 10
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negative rate).
– Sonoelastography of axillary LNs must still be
regarded as an experimental method. Nevertheless,
in the hands of an experienced sonographer, the
method of real-time sonoelastography may provide
useful information about axillary LNs even today.
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